LD-2 disclosure · 2nd Quarter - Report
LUPIN PHARMACEUTICALS INC
Expenses$75Kself-filed spend
Client
- Location
- Maryland · United States of America
Registrant
- Description
- Pharmaceutical Manufacturing
- Location
- Takoma Park, Maryland, United States of America
Lobbying activities
4 issuesHealth Issues
Patent Thickets, Patent Settlements, Interchangeability of biosimilars, Q1Q2 transparency, PBM Reform, Inflation Reduction Act, Abbreviated Drug Labeling, Tariffs, Domestic Manufacturing, DSCSA.
LobbyistsSHAWN BROWN esq
Covered position (SHAWN BROWN esq): VP Government Affairs
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Reimbursement of generic pharmaceuticals and biosimilars.
LobbyistsSHAWN BROWN esq
Covered position (SHAWN BROWN esq): VP Government Affairs.
TargetedSENATE · HOUSE OF REPRESENTATIVES
Pharmacy
Country of Origin labeling.
LobbyistsSHAWN BROWN esq
Covered position (SHAWN BROWN esq): VP Government Affairs
SENATE · HOUSE OF REPRESENTATIVES